345 related articles for article (PubMed ID: 29475165)
1. Non-acidic 1,3,4-trisubstituted-pyrazole derivatives as lonazolac analogs with promising COX-2 selectivity, anti-inflammatory activity and gastric safety profile.
Abdellatif KRA; Fadaly WAA; Elshaier YAMM; Ali WAM; Kamel GM
Bioorg Chem; 2018 Apr; 77():568-578. PubMed ID: 29475165
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1,5-diarylpyrazole derivatives.
Abdellatif KR; Fadaly WA; Ali WA; Kamel GM
J Enzyme Inhib Med Chem; 2016; 31(sup3):54-60. PubMed ID: 27541738
[TBL] [Abstract][Full Text] [Related]
3. New 1,2,4-triazole/pyrazole hybrids linked to oxime moiety as nitric oxide donor celecoxib analogs: Synthesis, cyclooxygenase inhibition anti-inflammatory, ulcerogenicity, anti-proliferative activities, apoptosis, molecular modeling and nitric oxide release studies.
Fadaly WAA; Elshaier YAMM; Hassanein EHM; Abdellatif KRA
Bioorg Chem; 2020 May; 98():103752. PubMed ID: 32197148
[TBL] [Abstract][Full Text] [Related]
4. Ligand based design and synthesis of pyrazole based derivatives as selective COX-2 inhibitors.
Murahari M; Mahajan V; Neeladri S; Kumar MS; Mayur YC
Bioorg Chem; 2019 May; 86():583-597. PubMed ID: 30782576
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of novel halogenated triarylpyrazoles as selective COX-2 inhibitors: Anti-inflammatory activity, histopatholgical profile and in-silico studies.
Abdellatif KRA; Abdelall EKA; Labib MB; Fadaly WAA; Zidan TH
Bioorg Chem; 2020 Dec; 105():104418. PubMed ID: 33166844
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of pyridazinone derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents.
Ahmed EM; Kassab AE; El-Malah AA; Hassan MSA
Eur J Med Chem; 2019 Jun; 171():25-37. PubMed ID: 30904755
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1,3,5-triarylpyrazoline and 1,5-diarylpyrazole derivatives as selective COX-2 inhibitors.
Abdellatif KRA; Abdelall EKA; Fadaly WAA; Kamel GM
Bioorg Med Chem Lett; 2016 Jan; 26(2):406-412. PubMed ID: 26691756
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, Anti-Inflammatory Activity, and COX-1/2 Inhibition Profile of Some Novel Non-Acidic Polysubstituted Pyrazoles and Pyrano[2,3-c]pyrazoles.
Faidallah HM; Rostom SAF
Arch Pharm (Weinheim); 2017 May; 350(5):. PubMed ID: 28370254
[TBL] [Abstract][Full Text] [Related]
9. New pyridazine derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents; design, synthesis and biological evaluation.
Ahmed EM; Hassan MSA; El-Malah AA; Kassab AE
Bioorg Chem; 2020 Jan; 95():103497. PubMed ID: 31838289
[TBL] [Abstract][Full Text] [Related]
10. Optimization of pyrazole-based compounds with 1,2,4-triazole-3-thiol moiety as selective COX-2 inhibitors cardioprotective drug candidates: Design, synthesis, cyclooxygenase inhibition, anti-inflammatory, ulcerogenicity, cardiovascular evaluation, and molecular modeling studies.
Abdellatif KRA; Abdelall EKA; Elshemy HAH; Philoppes JN; Hassanein EHM; Kahk NM
Bioorg Chem; 2021 Sep; 114():105122. PubMed ID: 34243075
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1-phenylpyrazolo[3,4-d]pyrimidine derivatives.
Bakr RB; Azouz AA; Abdellatif KR
J Enzyme Inhib Med Chem; 2016; 31(sup2):6-12. PubMed ID: 27210522
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and evaluation of some pyrazolo[3,4-d]pyrimidines as anti-inflammatory agents.
Tageldin GN; Fahmy SM; Ashour HM; Khalil MA; Nassra RA; Labouta IM
Bioorg Chem; 2018 Aug; 78():358-371. PubMed ID: 29627656
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, anti-inflammatory screening, molecular docking, and COX-1,2/-5-LOX inhibition profile of some novel quinoline derivatives.
Chaaban I; Rizk OH; Ibrahim TM; Henen SS; El-Khawass EM; Bayad AE; El-Ashmawy IM; Nematalla HA
Bioorg Chem; 2018 Aug; 78():220-235. PubMed ID: 29602046
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of new pyrazoles and pyrozolo [3,4-b] pyridines as anti-inflammatory agents by inhibition of COX-2 enzyme.
Mohamed LW; Shaaban MA; Zaher AF; Alhamaky SM; Elsahar AM
Bioorg Chem; 2019 Mar; 83():47-54. PubMed ID: 30342385
[TBL] [Abstract][Full Text] [Related]
15. Novel tetrazole and cyanamide derivatives as inhibitors of cyclooxygenase-2 enzyme: design, synthesis, anti-inflammatory evaluation, ulcerogenic liability and docking study.
Lamie PF; Philoppes JN; Azouz AA; Safwat NM
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):805-820. PubMed ID: 28587532
[TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase-2 and 15-lipoxygenase inhibition, synthesis, anti-inflammatory activity and ulcer liability of new celecoxib analogues: Determination of region-specific pyrazole ring formation by NOESY.
Abdelall EKA; Lamie PF; Ali WAM
Bioorg Med Chem Lett; 2016 Jun; 26(12):2893-2899. PubMed ID: 27158139
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and mechanistic study of novel diarylpyrazole derivatives as anti-inflammatory agents with reduced cardiovascular side effects.
Amin NH; Hamed MIA; Abdel-Fattah MM; Abusabaa AHA; El-Saadi MT
Bioorg Chem; 2021 Nov; 116():105394. PubMed ID: 34619468
[TBL] [Abstract][Full Text] [Related]
18. Selective cyclooxygenase inhibition and ulcerogenic liability of some newly prepared anti-inflammatory agents having thiazolo[4,5-d]pyrimidine scaffold.
Bakr RB; Ghoneim AA; Azouz AA
Bioorg Chem; 2019 Jul; 88():102964. PubMed ID: 31075742
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, cyclooxygenase inhibition and biological evaluation of new 1,3,5-triaryl-4,5-dihydro-1H-pyrazole derivatives possessing amino/methanesulfonyl pharmacophore.
Abdellatif KR; Fadaly WA
Bioorg Chem; 2017 Feb; 70():57-66. PubMed ID: 27894776
[TBL] [Abstract][Full Text] [Related]
20. Novel tetrazole-based selective COX-2 inhibitors: Design, synthesis, anti-inflammatory activity, evaluation of PGE
Labib MB; Fayez AM; El-Nahass ES; Awadallah M; Halim PA
Bioorg Chem; 2020 Nov; 104():104308. PubMed ID: 33011534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
